US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

FibroBiologics

1.26

-0.1200-8.70%

Post-market: 1.290.0300+2.38%16:46 EDT

Volume:418.48K

Turnover:553.63K

Market Cap:47.55M

PE:-3.71

High:1.53

Open:1.44

Low:1.20

Close:1.38

Loading ...

Overview Company News Filings

FibroBiologics Secures $25M Equity Agreement for Trials

Fibrobiologics Inc - Enters Into Standby Equity Purchase Agreement

THOMSON REUTERS

Fibrobiologics Inc - Investor to Advance $15 Million to Fibrobiologics

THOMSON REUTERS

FibroBiologics announces $25M financing

Fibrobiologics Announces $25 Million Financing

THOMSON REUTERS

Press Release: FibroBiologics Announces $25 Million Financing

FibroBiologics Resolves Commitments Through Share Issuance Agreement

FBLG: On Target to Initiate Phase 1/2 Trial in 2025…

Zacks Small Cap Research

FibroBiologics Files Patent Application for Methods to Treat Splenomegaly

MT Newswires Live

FibroBiologics files patent application for cell-based therapeutic

Fibrobiologics Files Patent Application for a Cell-Based Therapeutic for the Treatment of Splenomegaly

THOMSON REUTERS

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Promising Developments and Financial Stability Highlight FibroBiologics’ Near-Term Opportunities

FibroBiologics files patent application on reduction of clots related to IBMIR

Fibrobiologics Files Patent Application Covering Reduction of Blood Clots Associated With Instant Blood-Mediated Inflammatory Reaction (Ibmir) in Cell-Based Therapeutics

THOMSON REUTERS

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

FibroBiologics Reports Q3 2024 Financial Results

FibroBiologics Is Maintained at Buy by D. Boral Capital

FibroBiologics Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

FibroBiologics, Inc. Reports Net Loss $8.1M For Nine Months Ended Sept. 30

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FBLG/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBLG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":1.26,"timestamp":1745352000000,"preClose":1.38,"halted":0,"volume":418475,"hourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.26,"latestTime":"16:46 EDT","volume":715,"amount":892.520057,"timestamp":1745354793716},"delay":0,"floatShares":27939955,"shares":37735300,"eps":-0.339497,"marketStatus":"Post-Mkt","change":-0.12,"latestTime":"04-22 17:00:20 EDT","open":1.44,"high":1.53,"low":1.2,"amount":553633.6788725,"amplitude":0.23913,"askPrice":1.47,"askSize":2392,"bidPrice":1.2,"bidSize":11,"shortable":0,"etf":0,"ttmEps":-0.339497,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":4,"adr":0,"listingDate":1706677200000,"exchange":"NASDAQ","adjPreClose":1.38,"preHourTrading":{"tag":"盘前","latestPrice":1.4499,"preClose":1.38,"latestTime":"09:27 EDT","volume":4399,"amount":6409.2475417000005,"timestamp":1745328437049},"postHourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.26,"latestTime":"16:46 EDT","volume":715,"amount":892.520057,"timestamp":1745354793716},"volumeRatio":1.29738},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","floatShares":27939955,"roa":"-60.75%","roe":"-559.73%","lyrEps":-0.339497,"volumeRatio":1.29738,"shares":37735300,"dividePrice":0,"high":1.53,"amplitude":0.23913,"preClose":1.38,"low":1.2,"week52Low":0.7626,"pbRate":"17.38","week52High":13.59,"institutionHeld":0,"latestPrice":1.26,"committee":-0.990845,"eps":-0.339497,"divideRate":0,"volume":418475,"delay":0,"ttmEps":-0.339497,"open":1.44,"prevYearClose":2,"prevWeekClose":1.19,"prevMonthClose":0.9,"prevQuarterClose":0.9,"fiveDayClose":0.98,"twentyDayClose":1.11,"sixtyDayClose":1.68},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBLG\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2493750168","title":"FibroBiologics Secures $25M Equity Agreement for Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2493750168","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493750168?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:29","pubTimestamp":1734960561,"startTime":"0","endTime":"0","summary":"The latest update is out from FibroBiologics, Inc. ( ($FBLG) ). FibroBiologics, Inc. announced a $25 million Standby Equity Purchase Agreement with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-secures-25m-equity-agreement-for-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-secures-25m-equity-agreement-for-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","BK4215","BK4588","FBLG","EQR"],"gpt_icon":0},{"id":"2493752295","title":"Fibrobiologics Inc - Enters Into Standby Equity Purchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493752295","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493752295?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:08","pubTimestamp":1734959304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nFWN3NO09U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2493752262","title":"Fibrobiologics Inc - Investor to Advance $15 Million to Fibrobiologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2493752262","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493752262?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:08","pubTimestamp":1734959304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nFWN3NO09U:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2493618752","title":"FibroBiologics announces $25M financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2493618752","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493618752?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:00","pubTimestamp":1734958816,"startTime":"0","endTime":"0","summary":"FibroBiologics (FBLG) has entered into a Standby Equity Purchase Agreement with YA II PN, an investment fund managed by Yorkville Advisors Global. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-announces-25m-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-announces-25m-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2493275427","title":"Fibrobiologics Announces $25 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2493275427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493275427?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:55","pubTimestamp":1734958500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA1XLFCZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2493752830","title":"Press Release: FibroBiologics Announces $25 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2493752830","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493752830?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:55","pubTimestamp":1734958500,"startTime":"0","endTime":"0","summary":"HOUSTON, Dec. 23, 2024  -- FibroBiologics, Inc.  , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it has entered into a Standby Equity Purchase Agreement  with YA II PN LTD. , an investment fund managed by Yorkville Advisors Global, LP. The agreement allows FibroBiologics, subject to customary conditions, to sell up to $25 million in the aggregate of its common stock to Yorkville over the course of two years.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2493071408","title":"FibroBiologics Resolves Commitments Through Share Issuance Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2493071408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493071408?lang=en_us&edition=fundamental","pubTime":"2024-12-21 06:47","pubTimestamp":1734734877,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc. ( ($FBLG) ) has issued an announcement. FibroBiologics, Inc. has entered into a Side Letter Agreement with GEM Global Yield LL...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-resolves-commitments-through-share-issuance-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-resolves-commitments-through-share-issuance-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US3Y.BOND","US30Y.BOND","US10Y.BOND","FBLG","US7Y.BOND","US12M.BOND","BK4139","US5Y.BOND","US6M.BOND","US2Y.BOND"],"gpt_icon":0},{"id":"2485403094","title":"FBLG: On Target to Initiate Phase 1/2 Trial in 2025…","url":"https://stock-news.laohu8.com/highlight/detail?id=2485403094","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485403094?lang=en_us&edition=fundamental","pubTime":"2024-11-21 23:05","pubTimestamp":1732201500,"startTime":"0","endTime":"0","summary":"On Track to Initiate Phase 1/2 Trial in Diabetic Foot Ulcers. FibroBiologics, Inc.  is on track to initiate a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers  in the second quarter of 2025. We anticipate the trial being completed by the end of 2025.A patent was filed that covers methods employing fibroblasts or other Tissue Factor -expressing cells for the prevention of Instant Blood-Mediated Inflammatory Reaction . One of the most pressing challenges in cell therapy is IBMIR, which is a nonspecific response mediated by the innate immune system that is characterized by coagulation, complement activation, and platelet adhesion that ultimately endangers the effectiveness and safety of cell-based therapies. This novel approach to minimizing the risk of IBMIR could help make cell therapy treatment safer and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fblg-target-initiate-phase-1-150500508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2484315924","title":"FibroBiologics Files Patent Application for Methods to Treat Splenomegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2484315924","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484315924?lang=en_us&edition=fundamental","pubTime":"2024-11-20 00:06","pubTimestamp":1732032371,"startTime":"0","endTime":"0","summary":"FibroBiologics  said Tuesday it has filed a patent application covering methods to treat splenomegaly using a cell-based approach.\"This patent application highlights the potential of fibroblast-based therapies to address immune-related disorders, such as splenomegaly,\" said FibroBiologics Chief Executive Pete O'Heeron.Hamid Khoja, the biotechnology company's chief scientific officer said, \"unlike traditional treatments, fibroblasts may offer a potential solution aligned with the host biological processes to help regulate immune activity within the spleen, opening new possibilities for managing conditions that involve immune system overload and splenomegaly.\"Price: 2.41, Change: -0.09, Percent Change: -3.75","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2484940962","title":"FibroBiologics files patent application for cell-based therapeutic","url":"https://stock-news.laohu8.com/highlight/detail?id=2484940962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484940962?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:20","pubTimestamp":1732026038,"startTime":"0","endTime":"0","summary":"FibroBiologics (FBLG) announced the filing of a patent application covering methods for treatment of splenomegaly using a cell-based therapeutic ap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-patent-application-for-cell-based-therapeutic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-patent-application-for-cell-based-therapeutic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2484947246","title":"Fibrobiologics Files Patent Application for a Cell-Based Therapeutic for the Treatment of Splenomegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2484947246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484947246?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:15","pubTimestamp":1732025700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA47VM3V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2484994702","title":"FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2484994702","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484994702?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:15","pubTimestamp":1732025700,"startTime":"0","endTime":"0","summary":"HOUSTON, Nov.  19, 2024  (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/19/2983733/0/en/FibroBiologics-Files-Patent-Application-for-a-Cell-based-Therapeutic-for-the-Treatment-Of-Splenomegaly.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2483030231","title":"Promising Developments and Financial Stability Highlight FibroBiologics’ Near-Term Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2483030231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483030231?lang=en_us&edition=fundamental","pubTime":"2024-11-16 00:45","pubTimestamp":1731689114,"startTime":"0","endTime":"0","summary":"Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on FibroBiologics, Inc. (FBLG – Research Report). The associated price t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-developments-and-financial-stability-highlight-fibrobiologics-near-term-opportunities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-developments-and-financial-stability-highlight-fibrobiologics-near-term-opportunities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2483280959","title":"FibroBiologics files patent application on reduction of clots related to IBMIR","url":"https://stock-news.laohu8.com/highlight/detail?id=2483280959","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483280959?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:20","pubTimestamp":1731594034,"startTime":"0","endTime":"0","summary":"FibroBiologics (FBLG) announced the filing of a patent application with the United States Patent and Trademark Office covering methods employing fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-patent-application-on-reduction-of-clots-related-to-ibmir?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-patent-application-on-reduction-of-clots-related-to-ibmir?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2483806402","title":"Fibrobiologics Files Patent Application Covering Reduction of Blood Clots Associated With Instant Blood-Mediated Inflammatory Reaction (Ibmir) in Cell-Based Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2483806402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483806402?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:15","pubTimestamp":1731593705,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nFWN3ML0OS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2483680920","title":"FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2483680920","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483680920?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:15","pubTimestamp":1731593700,"startTime":"0","endTime":"0","summary":"HOUSTON, Nov. 14, 2024  -- FibroBiologics, Inc.  , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the filing of a patent application with the United States Patent and Trademark Office covering methods employing fibroblasts or other Tissue Factor -expressing cells to prevent IBMIR-mediated blood clotting.This communication contains \"forward-looking statements\" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the potential of fibroblasts and TF-expressing cells to reduce inflammatory and coagulative responses and adverse events, to potentially eliminate blood clotting triggered by the body’s inflammatory response, to potentially transform therapeutic protocols, to provide safer and more effective treatments, to minimize the risks of, a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/46sDxmY8j40BxoS97qkwpA--~B/aD0xODA7dz03MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cfb2d24db243682502da4090d359752f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/46sDxmY8j40BxoS97qkwpA--~B/aD0xODA7dz03MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cfb2d24db243682502da4090d359752f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fibrobiologics-files-patent-application-covering-141500388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","FBLG"],"gpt_icon":0},{"id":"2483818038","title":"FibroBiologics Reports Q3 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483818038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483818038?lang=en_us&edition=fundamental","pubTime":"2024-11-14 12:44","pubTimestamp":1731559459,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc. ( ($FBLG) ) has released its Q3 earnings. Here is a breakdown of the information FibroBiologics, Inc. presented to its investo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2483861669","title":"FibroBiologics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2483861669","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483861669?lang=en_us&edition=fundamental","pubTime":"2024-11-14 07:11","pubTimestamp":1731539460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FBLG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 18:11 ET (23:11 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG"],"gpt_icon":0},{"id":"2483004528","title":"FibroBiologics Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483004528","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483004528?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:44","pubTimestamp":1731501840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FBLG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 07:44 ET (12:44 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG"],"gpt_icon":0},{"id":"2483206505","title":"FibroBiologics, Inc. Reports Net Loss $8.1M For Nine Months Ended Sept. 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2483206505","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483206505?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:17","pubTimestamp":1731449837,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc. Reports Net Loss $8.1M For Nine Months Ended Sept. 30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41923576/fibrobiologics-inc-reports-net-loss-8-1m-for-nine-months-ended-sept-30","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBLG\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBLG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBLG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1730520000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FBLG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FBLG","date":"2025-04-21","current":-4.023386,"percent":0.680702,"low":-68.573467,"twenty":-19.61153,"median":-5.267231,"eighty":-3.105834,"high":-1.984604,"avg":-11.019411,"sd":12.208382,"marketCap":44905007},"quantilePoints":[{"date":"2024-02-02","current":-68.573467,"twenty":-68.573467,"median":-68.573467,"eighty":-68.573467,"marketCap":568611190},{"date":"2024-02-09","current":-30.642544,"twenty":-58.777258,"median":-48.452053,"eighty":-34.01244,"marketCap":254087971},{"date":"2024-02-16","current":-50.313332,"twenty":-58.777258,"median":-50.313332,"eighty":-30.642544,"marketCap":417198153},{"date":"2024-02-23","current":-47.413654,"twenty":-56.896385,"median":-48.5892,"eighty":-33.338461,"marketCap":393154022},{"date":"2024-03-01","current":-25.741365,"twenty":-54.984165,"median":-48.491237,"eighty":-33.338461,"marketCap":424346408},{"date":"2024-03-08","current":-19.47356,"twenty":-53.244359,"median":-47.492024,"eighty":-25.717713,"marketCap":321021631},{"date":"2024-03-15","current":-20.892685,"twenty":-51.363486,"median":-37.245189,"eighty":-20.955758,"marketCap":344415920},{"date":"2024-03-22","current":-23.849198,"twenty":-50.446561,"median":-28.99678,"eighty":-20.813845,"marketCap":393154022},{"date":"2024-03-28","current":-23.159345,"twenty":-50.219289,"median":-25.741365,"eighty":-20.93999,"marketCap":381781799},{"date":"2024-04-05","current":-22.469492,"twenty":-49.216157,"median":-24.637601,"eighty":-21.160743,"marketCap":370409575},{"date":"2024-04-12","current":-22.311811,"twenty":-48.471645,"median":-23.652097,"eighty":-21.298713,"marketCap":367810209},{"date":"2024-04-19","current":-21.700799,"twenty":-48.064123,"median":-23.20862,"eighty":-21.030656,"marketCap":357737668},{"date":"2024-04-26","current":-23.021374,"twenty":-47.63309,"median":-22.804563,"eighty":-21.030656,"marketCap":379507354},{"date":"2024-05-03","current":-13.245174,"twenty":-47.445002,"median":-22.479347,"eighty":-20.675875,"marketCap":218346696},{"date":"2024-05-10","current":-17.22661,"twenty":-43.252224,"median":-22.05558,"eighty":-19.871704,"marketCap":283980674},{"date":"2024-05-17","current":-17.017594,"twenty":-36.598639,"median":-21.769784,"eighty":-19.221271,"marketCap":383406402},{"date":"2024-05-24","current":-16.310932,"twenty":-31.990502,"median":-21.661379,"eighty":-18.255477,"marketCap":367485289},{"date":"2024-05-31","current":-17.767522,"twenty":-29.984238,"median":-21.543118,"eighty":-17.827098,"marketCap":400302277},{"date":"2024-06-07","current":-14.972667,"twenty":-28.19741,"median":-21.306597,"eighty":-17.252609,"marketCap":337334178},{"date":"2024-06-14","current":-10.427133,"twenty":-26.746956,"median":-21.178482,"eighty":-16.659936,"marketCap":234923317},{"date":"2024-06-21","current":-7.769521,"twenty":-25.741365,"median":-20.932105,"eighty":-16.368618,"marketCap":175047318},{"date":"2024-06-28","current":-6.767471,"twenty":-25.694061,"median":-20.88283,"eighty":-16.302279,"marketCap":152471122},{"date":"2024-07-05","current":-6.143005,"twenty":-25.43783,"median":-20.64631,"eighty":-15.81876,"marketCap":138401898},{"date":"2024-07-12","current":-7.689204,"twenty":-24.673079,"median":-20.183123,"eighty":-14.136173,"marketCap":173237756},{"date":"2024-07-15","current":-7.514809,"twenty":-24.649427,"median":-20.094427,"eighty":-13.517924,"marketCap":169308652},{"date":"2024-08-02","current":-7.974576,"twenty":-24.625775,"median":-20.005732,"eighty":-13.175194,"marketCap":179667198},{"date":"2024-08-09","current":-4.080921,"twenty":-24.140907,"median":-19.700225,"eighty":-10.836667,"marketCap":79459622},{"date":"2024-08-16","current":-2.166861,"twenty":-23.730937,"median":-18.842837,"eighty":-9.439605,"marketCap":42190950},{"date":"2024-08-23","current":-2.546062,"twenty":-23.640271,"median":-18.638558,"eighty":-7.79743,"marketCap":49574366},{"date":"2024-08-30","current":-2.915474,"twenty":-23.407692,"median":-18.172694,"eighty":-7.552859,"marketCap":56767191},{"date":"2024-09-06","current":-3.368187,"twenty":-23.218475,"median":-17.767522,"eighty":-6.924314,"marketCap":65581972},{"date":"2024-09-13","current":-5.722296,"twenty":-23.104157,"median":-17.428613,"eighty":-6.143005,"marketCap":111418835},{"date":"2024-09-20","current":-5.722296,"twenty":-22.93465,"median":-17.22661,"eighty":-5.90745,"marketCap":111418835},{"date":"2024-09-27","current":-5.686079,"twenty":-22.765143,"median":-16.563311,"eighty":-5.873037,"marketCap":110713652},{"date":"2024-10-04","current":-4.798761,"twenty":-22.619289,"median":-16.368618,"eighty":-5.722296,"marketCap":93436681},{"date":"2024-10-11","current":-4.20118,"twenty":-22.481318,"median":-16.080185,"eighty":-5.265962,"marketCap":81801170},{"date":"2024-10-18","current":-6.012033,"twenty":-22.40642,"median":-15.807485,"eighty":-5.066768,"marketCap":117060295},{"date":"2024-10-25","current":-5.215258,"twenty":-22.209319,"median":-15.237992,"eighty":-5.131958,"marketCap":101546280},{"date":"2024-10-31","current":-5.342017,"twenty":-22.020102,"median":-13.586112,"eighty":-5.110228,"marketCap":104014418},{"date":"2024-11-08","current":-6.464746,"twenty":-21.866364,"median":-12.649071,"eighty":-5.128337,"marketCap":125875076},{"date":"2024-11-15","current":-5.477931,"twenty":-21.799349,"median":-10.768411,"eighty":-5.146445,"marketCap":97392141},{"date":"2024-11-22","current":-4.698155,"twenty":-21.716567,"median":-9.773622,"eighty":-5.018763,"marketCap":83528491},{"date":"2024-11-29","current":-5.107537,"twenty":-21.700799,"median":-9.003931,"eighty":-5.016064,"marketCap":90806907},{"date":"2024-12-06","current":-4.639671,"twenty":-21.661379,"median":-7.895306,"eighty":-4.997955,"marketCap":82488717},{"date":"2024-12-13","current":-4.425233,"twenty":-21.562828,"median":-7.720912,"eighty":-4.979847,"marketCap":78676213},{"date":"2024-12-20","current":-3.957367,"twenty":-21.543118,"median":-7.546517,"eighty":-4.853087,"marketCap":70358023},{"date":"2024-12-27","current":-4.50321,"twenty":-21.511582,"median":-7.203145,"eighty":-4.778145,"marketCap":80062578},{"date":"2025-01-03","current":-3.869642,"twenty":-21.385437,"median":-6.905845,"eighty":-4.698155,"marketCap":68798363},{"date":"2025-01-10","current":-4.065278,"twenty":-21.306597,"median":-6.609614,"eighty":-4.652603,"marketCap":72276579},{"date":"2025-01-17","current":-3.769263,"twenty":-21.298713,"median":-6.286711,"eighty":-4.50321,"marketCap":67013721},{"date":"2025-01-24","current":-3.157497,"twenty":-21.243525,"median":-6.193118,"eighty":-4.433031,"marketCap":56137148},{"date":"2025-01-31","current":-3.295638,"twenty":-21.050366,"median":-6.140899,"eighty":-4.36675,"marketCap":58593149},{"date":"2025-02-07","current":-3.157497,"twenty":-20.955758,"median":-6.004281,"eighty":-4.203103,"marketCap":56137148},{"date":"2025-02-14","current":-2.545732,"twenty":-20.888743,"median":-5.948653,"eighty":-4.068407,"marketCap":45260576},{"date":"2025-02-21","current":-2.447061,"twenty":-20.872975,"median":-5.908467,"eighty":-3.946872,"marketCap":43506290},{"date":"2025-02-28","current":-2.348389,"twenty":-20.794135,"median":-5.885273,"eighty":-3.784683,"marketCap":41752004},{"date":"2025-03-07","current":-2.210248,"twenty":-20.498484,"median":-5.867165,"eighty":-3.670591,"marketCap":39296004},{"date":"2025-03-14","current":-2.109947,"twenty":-20.183123,"median":-5.776622,"eighty":-3.453513,"marketCap":37512750},{"date":"2025-03-21","current":-2.151728,"twenty":-20.183123,"median":-5.722296,"eighty":-3.368187,"marketCap":38255577},{"date":"2025-03-28","current":-2.130838,"twenty":-20.005732,"median":-5.595537,"eighty":-3.295638,"marketCap":37884163},{"date":"2025-04-04","current":-2.958372,"twenty":-19.926892,"median":-5.518575,"eighty":-3.165965,"marketCap":33018387},{"date":"2025-04-11","current":-2.748074,"twenty":-19.788921,"median":-5.342017,"eighty":-3.105834,"marketCap":30671251},{"date":"2025-04-17","current":-3.685286,"twenty":-19.647008,"median":-5.282987,"eighty":-3.104326,"marketCap":41131477},{"date":"2025-04-21","current":-4.023386,"twenty":-19.61153,"median":-5.267231,"eighty":-3.105834,"marketCap":44905007}],"updateTime":1745320702429}}}